Indaptus Therapeutics, Inc. financial data

Symbol
INDP on Nasdaq
Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 12 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 146% % -69%
Debt-to-equity 36% % 155%
Return On Equity -697% % -293%
Return On Assets -255% % -81%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1,751,163 shares -83%
Common Stock, Shares, Outstanding 1,641,920 shares -84%
Entity Public Float $15,039,986 USD 13%
Common Stock, Value, Issued $16,420 USD -84%
Weighted Average Number of Shares Outstanding, Basic 997,038 shares 194%
Weighted Average Number of Shares Outstanding, Diluted 997,038 shares 194%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $8,975,622 USD 32%
General and Administrative Expense $6,873,757 USD -20%
Operating Income (Loss) $15,849,379 USD -3.1%
Nonoperating Income (Expense) $247,291 USD -72%
Net Income (Loss) Attributable to Parent $16,867,513 USD -13%
Earnings Per Share, Basic 8 USD/shares 67%
Earnings Per Share, Diluted 8 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $5,825,639 USD -21%
Assets, Current $6,438,993 USD -16%
Operating Lease, Right-of-Use Asset $8,487 USD -92%
Other Assets, Noncurrent $392,572 USD -22%
Assets $6,840,052 USD -17%
Accounts Payable, Current $707,420 USD 27%
Employee-related Liabilities, Current $43,389 USD -95%
Liabilities, Current $2,234,325 USD 0.08%
Operating Lease, Liability, Noncurrent $4,007 USD -96%
Liabilities $3,393,881 USD 19%
Retained Earnings (Accumulated Deficit) $73,175,649 USD -30%
Stockholders' Equity Attributable to Parent $4,605,727 USD -23%
Liabilities and Equity $6,840,052 USD -17%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $5,047,127 USD -28%
Net Cash Provided by (Used in) Financing Activities $3,151,395 USD 897%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 1,641,920 shares -84%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Deferred Tax Assets, Valuation Allowance $56,945,994 USD 4.5%
Deferred Tax Assets, Gross $56,963,334 USD 4.5%
Operating Lease, Liability $8,686 USD -92%
Depreciation $735 USD 129%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $15,022,027 USD 3.2%
Lessee, Operating Lease, Liability, to be Paid $8,686 USD -92%
Operating Lease, Liability, Current $8,686 USD -92%
Lessee, Operating Lease, Liability, to be Paid, Year One $86,862 USD -15%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $372 USD -95%
Deferred Tax Assets, Operating Loss Carryforwards $53,447,116 USD 3.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5,000,000 shares
Operating Lease, Payments $26,059 USD 3%
Additional Paid in Capital $77,764,956 USD 25%
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares